Vivimed Labs receives EIR from USFDA

PTI New Delhi | Updated on October 05, 2018 Published on October 05, 2018

Vivimed Labs has received establishment inspection report (EIR) from the US health regulator for its Mexico manufacturing facility.

“The company’s API manufacturing facility located in Cuernavaca, Mexico was recently inspected by the United States Food and Drug Administration (USFDA) in compliance with its requirements,” Vivimed Labs said in a BSE filing today.

“The inspection was successful and the company obtained EIR. This was a routine inspection by the USFDA,” it added.

Shares of Vivimed Labs were trading at Rs 40 per scrip on BSE, up 2.17 per cent, from its previous close.

Published on October 05, 2018
This article is closed for comments.
Please Email the Editor